SciTech Development Inc. is a clinical-stage pharmaceutical company focused on pioneering advanced cancer treatments through its proprietary nanotechnology drug-delivery platform. The company is currently conducting clinical trials for its lead drug candidate, ST-001 nanoFenretinide™, which has shown promising results in treating T-cell Non-Hodgkin Lymphoma. With its innovative approach, SciTech aims to provide more effective and accessible treatment options across a broad range of cancers.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$6M
Total Amount Raised$6M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$6M
Latest Funding Amount$6M
Latest Funding RoundConvertible Notes
Latest Funding RoundConvertible Notes
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 24, 2025
Convertible Notes
$5.50M
―
Similar Companies
A snapshot of private companies similar to SciTech Development Inc, helping you discover and navigate related company profiles.